Acceleron Pharma Insider Trades

XLRN

Track insider trading activity from Acceleron Pharma executives and directors. See which insiders are buying and selling XLRN stock.

Trades Last 12 Months

XLRN Price

All Insider Trades for Acceleron Pharma

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mccourt Thomas A Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$576k 3,222 shares
$178.75
$178.75
Mclaughlin Kevin F Svp, CFO And Treasurer
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$1.91M 10,681 shares
$178.75
$178.75
Backstrom Jay T. Evp, Research And Development
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$21.1M 117,859 shares
$178.75
$178.75
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$576k 3,222 shares
$178.75
$178.75
Malik Kemal Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$576k 3,222 shares
$178.75
$178.75
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$6.17M 34,499 shares
$178.75
$178.75
Nader Francois Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$576k 3,222 shares
$178.75
$178.75
Dable Habib J CEO And President
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$17.6M 98,450 shares
$178.75
$178.75
Veness Adam M Svp, General Counsel And Sec.
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.36M 18,806 shares
$178.75
$178.75
Smith Karen L. Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$290k 1,622 shares
$178.75
$178.75
Hamill Laura Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$168k 941 shares
$178.75
$178.75
Hite Christopher Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$166k 930 shares
$178.75
$178.75
Kango Sujay Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.74M 20,896 shares
$178.75
$178.75
Celgene Corp /De/ 10% owner
Holding Value $1.25B 7,010,751 shares
Last Trade
Jul 09, 2020 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$3.92M 38,979 shares
$100.68
$178.75
George Jean Director
Holding Value $1.46M 8,185 shares
Last Trade
Jan 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$507k 9,562 shares
$52.99
$178.75
Quisel John D Evp, Chief Business Officer
Holding Value $10.3M 57,558 shares
Last Trade
Jan 02, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$307k 5,842 shares
$52.52
$178.75
Kumar Ravindra SVP & Chief Scientific Officer
Holding Value $15.5M 86,986 shares
Last Trade
Sep 10, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$153k 3,389 shares
$45.24
$178.75
Zeldin Robert K EVP & Chief Medical Officer
Holding Value $3.41M 19,103 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$633k 15,200 shares
$41.64
$178.75
Maniatis Tom Director
Holding Value $24.4M 136,731 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$364k 8,750 shares
$41.64
$178.75
Pops Richard F Director
Holding Value $1.34M 7,500 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$312k 7,500 shares
$41.64
$178.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up